Media Room

  • EVALUATING T-CELL DRIVEN IMMUNITY IN POST VIRAL SYNDROMES

    13 June 2024
    Dr. Nigel McCracken, Presentation

    view

  • From Rugby Fields to Research Labs with Nigel McCracken (Spotify)

    14 May 2024
    Jeff Harmon, Conversations Life Science Leaders Aren’t Having

    view

  • From Rugby Fields to Research Labs with Nigel McCracken (YouTube)

    13 May 2024
    Jeff Harmon, Conversations Life Science Leaders Aren’t Having

    view

  • Nigel McCracken & Sean Knight - Research into T-Cell Exhaustion

    30 April 2024
    Jackie Baxter, Long Covid Podcast

    view

  • Virax Biolabs Launches Portfolio of Immune Profiling Solutions Evaluating Adaptive Immunity in Post-Viral Syndromes at ESCMID Global 2024

    25 April 2024
    Virax Biolabs, Press Release

    view

  • Virax Biolabs to Participate at ESCMID Global 2024

    16 April 2024
    Virax Biolabs, Press Release

    view

  • Post-Viral Syndromes and the Utility of T-cell Diagnostics

    10 April 2024
    Dr. Nigel McCracken, Clinical Lab Products

    view

  • James Foster CEO & Nigel McCracken COO - Virax Biolabs

    8 January 2024
    Don Davis PhD, Life Science Success Podcast

    view

  • Virax Biolabs Partners With University of Manchester, Northern Care Alliance on Long COVID Study

    4 January 2024
    Staff Reporter, 360Dx

    view

  • Identifying Post-Viral Syndromes Such as Long COVID

    27 December 2023
    John Parkinson, Contagion Live

    view

  • Virax Biolabs Forges Strategic Research Collaboration with University of Manchester and the Northern Care Alliance Foundation Trust to Enhance Understanding of Immune Responses in COVID Patients

    21 December 2023
    Virax Biolabs, Press Release

    view

  • Virax Biolabs' CEO James Foster Issues Letter to Shareholders

    18 December 2023
    Virax Biolabs, Press Release

    view

  • Dr. Nigel McCracken, Ph.D. - Chief Operating Officer, Virax Biolabs

    22 November 2023
    Ira Pastor, Progress, Potential, And Possibilities

    view

  • 16 Clinical Laboratory Predictions for 2024

    21 November 2023
    Chris Wolski, Clinical Lab Products

    view

  • “Regulatory reforms and incentives implemented by Middle Eastern countries have simplified market entry for life sciences companies”

    4 October 2023
    Ayesha Siddiqui, BioSpectrum Asia

    view

  • Could a Predictive Test Fuel a Diagnostic Revolution?

    2 October 2023
    Chris Wolski, Clinical Lab Products

    view

  • T Cell Secrets

    15 September 2023
    James Foster, ID Transmission

    view

  • Virax Biolabs Group Announces Early-Access Program Launch of Research Use Only ViraxImmune Product and Hosts Webinar

    12 September 2023
    Virax BIolabs, Press Release

    view

  • Virax Biolabs Group Appoints Dr. Nigel McCracken as Chief Operating Officer to Oversee Growth Momentum

    1 September 2023
    Virax Biolabs, Press Release

    view

  • Virax Biolabs Group Continues Growth and Expansion with the Addition of Research and Laboratory Facilities

    18 July 2023
    Virax Biolabs, Press Release

    view

  • Abu Dhabi, Dubai Serve as Gateway to International Markets for Biopharma

    17 July 2023
    Lisa Munger, BioSpace

    view

  • How Virax Biolabs is Developing a Potentially Game-Changing Immunology Platform for T-Cell Testing

    13 July 2023
    Chris Leidl, Rx for Biotech

    view

  • Better Health Care Tests, Faster

    15 June 2023
    Andy Oram, Healthcare IT Today

    view

  • Virax Biolabs' CEO James Foster Issues Letter to Shareholders

    14 June 2023
    Virax Biolabs, Press Release

    view

  • Virax Biolabs readies clinical performance study of ViraxImmune Platform

    1 June 2023
    Leonard Zehr, BioTuesdays

    view

  • Virax Biolabs Group Announces Establishment of Regional Headquarters at Dubai Science Park

    4 May 2023
    Virax Biolabs, Press Release

    view

  • Virax Biolabs Group Limited Has Entered into an Agreement for the Distribution of Marburg Virus PCR Testing Kits

    19 April 2023
    Virax Biolabs, Press Release

    view

  • Virax Biolabs Group Limited Announces $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules

    8 March 2023
    Virax Biolabs, Press Release

    view

  • Virax Biolabs Group Limited Introduces Avian Influenza A Virus Real-Time PCR Test Kit

    7 March 2023
    Virax Biolabs, Press Release

    view

  • VRAX: INITIATION: Innovative Biotechnology Company Developing A Potentially Groundbreaking Immunology Platform Based Around Proprietary T-Cell Testing Technology

    16 February 2023
    Thomas Kerr, CFA, Zacks Small Cap Research

    view

  • Scrip Asks…What Does 2023 Hold For Biopharma? Part 5: Technological Advances (feat. James Foster, CEO)

    27 January 2023
    Eleanor Malone, Scrip Pharma Intelligence

    view

  • Molecular Diagnostics Adapts to Evolving Diseases (feat. Dr. Tomasz George, CSO)

    2 February 2023
    Anjali A. Sarkar, PhD, Genetic Engineering & Biotechnology News

    view

  • Virax Biolabs Group Limited Announces Purchase Order to Launch COVID-19 and Influenza A+B Antigen Combo Rapid Tests with Cosmos Health (NASDAQ:COSM)

    7 February 2023
    Virax Biolabs, Press Release

    view

  • Virax Biolabs to Present at the 2023 BIO CEO & Investor Conference

    6 February 2023
    Virax Biolabs, Press Release

    view

  • Virax Biolabs' CEO James Foster Issues Letter to Shareholders

    2 February 2023
    Virax Biolabs, Press Release

    view

  • Virax Biolabs Introduces Human Papillomavirus ("HPV") Test Kit

    4 January 2023
    Virax Biolabs, Press Release

    view

  • Determining Long Term Immunity May Aid in Understanding Vaccine Efficacy – Interview with Dr. Tomasz George, CSO

    22 December 2022
    John Parkinson, Contagion Live

    view

  • Virax Biolabs Preparing T-Cell Testing Platform to Provide Consumers With Immune Status Info

    16 December 2022
    Kelsy Ketchum, 360 Dx

    view

  • COVID-19 Rapid Antigen Test Distributed By Virax Biolabs Receives Emergency Use Authorization in the United States

    6 December 2022
    Virax Biolabs, Press Release

    view

  • Assessing Adaptive Immune Responses to Viruses to Inform Decisions about Vaccinations with Dr. Tomasz George

    1 December 2022
    Karen Jagoda, Empowered Patient Podcast

    view

  • In Every Crisis There Is An Opportunity – Interview with Chief Executive, James Foster

    23 November 2022
    Tom Hickey, Med Tech Gurus

    view

  • Virax Biolabs Appoints Richard Pallin as the Vice President of In Vitro Diagnostic Sales

    15 November 2022
    Virax Biolabs, Press Release

    view

  • Virax Biolabs Announces Closing of $3.8 Million Private Placement

    8 November 2022
    Virax Biolabs, Press Releases

    view

  • Virax Biolabs Announces $3.8 Million Private Placement

    4 November 2022
    Virax Biolabs, Press Release

    view

  • Virax Biolabs Introduces RSV-Influenza-COVID Triple Virus Antigen Rapid Test Kit

    3 November 2022
    Virax Biolabs, Press Releases

    view

  • Virax Biolabs Announces Initiation of its Virax Immune COVID-19 Analytical Performance Study

    26 October 2022
    Virax Biolabs, Press Releases

    view

  • Monkeypox Diagnosis and Immune Profiling Using Proprietary T-cell Test Technology

    30 September 2022
    Radio Interview, Health Professional Radio

    view

  • Virax Biolabs Group Limited Announces Distribution Agreement to Market Monkeypox Virus Real-Time PCR Detection Kit with Cosmos Holdings Inc.

    22 September 2022
    Virax Biolabs, Press Releases

    view

  • Virax Biolabs Introduces Monkeypox Virus Antigen Rapid Test Kit

    20 September 2022
    Virax Biolabs, Press Releases

    view

  • Virax BioLabs Presents at H.C. Wainwright's 24th Annual Global Investment Conference

    12 September 2022
    Virax Biolabs, Press Releases

    view

  • Virax Biolabs Group Limited to Present at H.C. Wainwright's 24th Annual Global Investment Conference in New York, NY

    6 September 2022
    Virax Biolabs, Press Releases

    view

  • Virax Biolabs Announces NASDAQ Closing Bell Ringing to Celebrate Initial Public Offering

    16 August 2022
    Virax Biolabs, Press Releases

    view

  • Benzinga Interview with Chief Executive, James Foster

    4 August 2022
    Video Interview, Benzinga

    view

  • Virax Biolabs Introduces Monkeypox and Varicella-Zoster Viruses Real-Time PCR Detection Kit

    26 July 2022
    Virax Biolabs, Press Releases

    view

  • Virax Biolabs Bucks the Market Trend

    26 July 2022
    Video Interview, Proactive

    view

  • Virax Biolabs Group Limited Completes Initial Public Offering; Shares Begin Trading Today on NASDAQ Capital Market as VRAX

    21 July 2022
    Virax Biolabs, Press Releases

    view

  • Virax Biolabs Group Limited Announces Pricing of $6.75 Million Initial Public Offering

    20 July 2022
    Virax Biolabs, Press Releases

    view

  • Virax Biolabs Announces the Formation of Advisory Board of Industry Leaders

    31 May 2022
    Virax Biolabs, Press Releases

    view

  • Virax Biolabs Introduces New Board of Directors, Announces Members

    17 May 2022
    Virax Biolabs, Press Releases

    view

  • Virax Biolabs Receives Ethical Approval for its Virax Immune COVID-19 Analytical Performance Study from the SBEBO Foundation for the Assessment of Ethics of Biomedical Research

    9 May 2022
    Virax Biolabs, GlobeNewswire

    view

  • Virax Biolabs Announces the Appointment of Jason D. Davis as Chief Financial Officer

    28 April 2022
    Virax Biolabs, Press Release

    view

  • Common cold may protect against SARS-CoV-2 infection and lead the way to new vaccines

    14 January 2022
    Katharine Lang, Medical News Today

    view

  • EXPLAINED: You May Never Forget The Omicron Variant, Here's Why Your T Cells Certainly Won't Anytime Soon

    31 December 2021
    Kenneth Mohanty, News 18

    view

  • Beyond the spike: Are T cell COVID-19 vaccines the future?

    20 December 2021
    Debbie Lambert, Medical News Today

    view

  • Sales of PPE in the UK overtake sandwiches with the masks and hand sanitiser industry now worth more than £8.7BILLION

    21 September 2020
    Jack Elsom, Daily Mail

    view

  • Coronavirus warning: The 5 most likely places to catch coronavirus in an office

    9 September 2020
    Georgina Laud, Express

    view

  • Experts reveal ‘Covid hotspots’ in the office – and how to limit your risk

    7 September 2020
    Natalie Morris, Metro

    view

  • Face coverings to be made compulsory on public transport in England

    4 June 2020
    Rowena Mason, The Guardian

    view